07630

8.1007.06%
YT

Ye Tian

Executive VP, Chief Scientific Officer & Executive Director

Dr. Ye Tian, also known as Edward, is Executive VP and Chief Scientific Officer of IMPACT Therapeutics, Inc and has been its Executive Director since September 23, 2025. Dr. Tian joined the IMPACT Therapeutics, Inc. in October 2009. Dr. Tian was Director of IMPACT Therapeutics, Inc from June 2014 to September 23, 2025. Dr. Tian has extensive experience in the research and development in biotech and pharma industry. Prior to joining our Group since 1996, Dr. Tian worked at Parke, Davis & Co. until it was acquired by Pfizer Inc. in 2000 and Dr. Tian continued to work at Pfizer Inc. until 2002. He also worked at TransTech Pharma, Inc. from 2005 to 2009. Dr. Tian obtained his bachelor’s degree in physical chemistry and instrumental analysis from Tsinghua University in the PRC in July 1982, his master’s degree in molecular biology from Chinese Academy of Science in the PRC in April 1986. Dr. Tian received his PhD in Neuroscience and Pharmacology from Michigan State University in March 1992.

Positions